Literature DB >> 1811361

Disseminated intravascular coagulopathy associated with rifampicin.

M Ip1, K P Cheng, W C Cheung.   

Abstract

A case of subclinical disseminated intravascular coagulopathy due to antituberculosis drugs, probably rifampicin, is described. The patient also developed marked leucocytosis, a 'flu-like illness, intravascular haemolysis, and acute renal failure as part of the drug reaction.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1811361     DOI： 10.1016/0041-3879(91)90056-x

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


  4 in total

Review 1.  Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.

Authors:  Thomas C Havey; Christine Cserti-Gazdewich; Michelle Sholzberg; Jay S Keystone; Wayne L Gold
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 2.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

3.  Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.

Authors:  Guo Chen; Jian-Qing He
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  Rifampicin-Induced Fever in a Patient with Brucellosis: A Case Report.

Authors:  Mesut Yilmaz; Canan Yasar; Selda Aydin; Okan Derin; Bahadir Ceylan; Ali Mert
Journal:  Drug Saf Case Rep       Date:  2018-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.